I have two brief questions. I agree with the noble Baroness, Lady Walmsley, in what she said about 200 being two a week. That is really pathetic in terms of what the need is likely to be. I wondered if the problem was because early on, there was a certain nervousness among GPs and clinicians in terms of the legal issues as regards prescribing cannabis products. Is that still an issue? The other thing I want to ask the Minister about is whether the MHRA is drawing on international experience because some countries are much further ahead on these issues than we are.
Medicines and Medical Devices Bill
Proceeding contribution from
Baroness Thornton
(Labour)
in the House of Lords on Wednesday, 11 November 2020.
It occurred during Debate on bills
and
Committee proceeding on Medicines and Medical Devices Bill.
About this proceeding contribution
Reference
807 c503GC Session
2019-21Chamber / Committee
House of Lords Grand CommitteeSubjects
Librarians' tools
Timestamp
2024-04-29 17:14:38 +0100
URI
http://hansard.intranet.data.parliament.uk/Lords/2020-11-11/20111182000036
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2020-11-11/20111182000036
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2020-11-11/20111182000036